Sára Cósta Ferreira-Rodrigues1, Cássio Milhomens Rodrigues1, Marcio Galdino Dos Santos1, Jean Antonio Abraham Gautuz2, Magali Glauzer Silva2, José Carlos Cogo3, Camila Batista-Silva4, Cleiton Pita Dos Santos4, Francisco Carlos Groppo4, Karina Cogo-Müller5, Yoko Oshima-Franco2. 1. Environmental Sciences Post-Graduate Program, PGCiamb, Tocantins Federal University (UFT), Palmas, Tocantins, Brazil. 2. Post-Graduate Program in Pharmaceutical Sciences and Pharmacy, University of Sorocaba (UNISO), Sorocaba, SP, Brazil. 3. Post-Graduate Program in Animal Production, University Camilo Castelo Branco (UNICASTELO), Descalvado, SP, Brazil. 4. Piracicaba Dental School, Department of Pharmacology, University of Campinas (UNICAMP), Piracicaba, SP Brazil. 5. Piracicaba Dental School, Department of Pharmacology, University of Campinas (UNICAMP), Piracicaba, SP Brazil.; Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Rua Sérgio Buarque de Holanda, Campinas, SP, Brazil.
Abstract
Purpose: The aim of this study was to evaluate the antibothropic and anti-inflammatory properties of J. elliptica. Methods: Phytochemical screening and thin-layer chromatography (TLC) assays were performed on J. elliptica hydroalcoholic extract (TE) in order to observe its main constituents. The antibothropic activity of TE was evaluated by the in vitro neuromuscular blockade caused by Bothrops jararacussu venom (Bjssu), in a mouse phrenic nerve-diaphragm model (PND). A quantitative histological study was carried out to observe a possible protection of TE against the venom myotoxicity. The anti-inflammatory activity was also evaluated in two models, Bjssu-induced paw edema, and carrageenan-induced neutrophils migration in the peritoneal cavity. Results: TLC analysis revealed several compounds in TE, such as saponins, alkaloids, and phenolic constituents. TE was able to neutralize the blockade and the myotoxicity induced by venom, when it was pre-incubated for 30 min with venom. In addition, it showed anti-inflammatory activity, inducing less neutrophils migration and reducing paw edema. Conclusion: J. elliptica showed both antibothropic and anti-inflammatory properties.
Purpose: The aim of this study was to evaluate the antibothropic and anti-inflammatory properties of J. elliptica. Methods: Phytochemical screening and thin-layer chromatography (TLC) assays were performed on J. elliptica hydroalcoholic extract (TE) in order to observe its main constituents. The antibothropic activity of TE was evaluated by the in vitro neuromuscular blockade caused by Bothrops jararacussu venom (Bjssu), in a mouse phrenic nerve-diaphragm model (PND). A quantitative histological study was carried out to observe a possible protection of TE against the venom myotoxicity. The anti-inflammatory activity was also evaluated in two models, Bjssu-induced paw edema, and carrageenan-induced neutrophils migration in the peritoneal cavity. Results: TLC analysis revealed several compounds in TE, such as saponins, alkaloids, and phenolic constituents. TE was able to neutralize the blockade and the myotoxicity induced by venom, when it was pre-incubated for 30 min with venom. In addition, it showed anti-inflammatory activity, inducing less neutrophils migration and reducing paw edema. Conclusion: J. elliptica showed both antibothropic and anti-inflammatory properties.
Authors: R Milani Júnior; M T Jorge; F P de Campos; F P Martins; A Bousso; J L Cardoso; L A Ribeiro; H W Fan; F O França; I S Sano-Martins; D Cardoso; C Ide Fernandez; J C Fernandes; V L Aldred; M P Sandoval; G Puorto; R D Theakston; D A Warrell Journal: QJM Date: 1997-05
Authors: C W S Wanderley; C M S Silva; D V T Wong; R M Ximenes; D F C Morelo; F Cosker; K S Aragão; C Fernandes; R C Palheta-Júnior; A Havt; G A C Brito; F Q Cunha; R A Ribeiro; R C P Lima-Júnior Journal: Toxicon Date: 2014-08-12 Impact factor: 3.033
Authors: Natália Tribuiani; Alexandro Mateus da Silva; Miriéle Cristina Ferraz; Magali Glauzer Silva; Ana Paula Guerreiro Bentes; Talita Signoreti Graziano; Marcio Galdino dos Santos; José Carlos Cogo; Eliana Aparecida Varanda; Francisco Carlos Groppo; Karina Cogo; Yoko Oshima-Franco Journal: BMC Complement Altern Med Date: 2014-02-08 Impact factor: 3.659
Authors: Juliana Félix-Silva; Thiago Souza; Yamara A S Menezes; Bárbara Cabral; Rafael B G Câmara; Arnóbio A Silva-Junior; Hugo A O Rocha; Ivanise M M Rebecchi; Silvana M Zucolotto; Matheus F Fernandes-Pedrosa Journal: PLoS One Date: 2014-08-15 Impact factor: 3.240
Authors: Carina Denny; Priscilla S Melo; Marcelo Franchin; Adna P Massarioli; Keityane B Bergamaschi; Severino M de Alencar; Pedro L Rosalen Journal: BMC Complement Altern Med Date: 2013-09-24 Impact factor: 3.659